EssilorLuxottica (EL) | Stock Overview & Key Data

What is EL's 52-week high and low?

In the last 52 weeks, EssilorLuxottica reached a high of €323.80 (on November 13, 2025) and a low of €162.50 (on May 12, 2026).

What is the market cap and P/E ratio for EL?

Curious about EssilorLuxottica's size and valuation? Its market capitalization stands at 88.12B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.

Does EL pay dividends? If so, what's the yield?

Yes, EssilorLuxottica is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.64%, and the company has paid an average of €3.71 per share annually over the past 3 years.

Who are EssilorLuxottica's main competitors or similar companies to consider before investing?

When looking at EssilorLuxottica, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sartorius Stedim DIM	15.79B	Healthcare	Medical Instruments & Supplies	6.42%	6.42%
Amplitude Surgical AMPLI	302.26M	Healthcare	Medical Instruments & Supplies	95.31%	105.59%
Crossject S.A ALCJ	105.59M	Healthcare	Medical Instruments & Supplies	6.04%	-50.89%
Visiomed Group SA ALVMG	52.83M	Healthcare	Medical Instruments & Supplies	0.00%	0.00%
Spineway S.A ALSPW	5.76M	Healthcare	Medical Instruments & Supplies	-25.00%	-25.00%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for EssilorLuxottica S.A.? (e.g., ROE, Debt/Equity)

To get a sense of EssilorLuxottica's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for EL?

Looking at EssilorLuxottica's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of EL stock is held by insiders and institutions?

Wondering who owns EssilorLuxottica stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.